Evaluation of the efficacy of treatment with ANW for facial acne

Not Applicable

Completed

• Conditions: Facial acne; Skin and Connective Tissue Diseases; Acne

• Registration Number: ISRCTN75516184
• Lead Sponsor: Applied Pharma Research (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-08-16
• Last Update Posted: 8 May 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Male or female patients with acne
2. Above age 18
3. Able to comply with the study procedures, in the opinion of the investigator, and able to give a voluntary written informed consent for participation in the trial
4. Diagnosis of severity of facial acne either 2 or 3 grade according to the Investigator?s Global Assessment (IGA) scale
5. The patient can exclude to become pregnant during the study

Exclusion Criteria

1. Pregnancy
2. Breastfeeding
3. More than one nodulo-cystic lesion per side of the face
4. Subject with facial acne who used any topical treatment in the last 7 days, and/or systemic antibiotic therapy in the last 30 days and/or systemic retinoid in the last six months
5. Cancer or history of cancer
6. Significant history of hematologic, cardiovascular, renal, neurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic disease
7. Reported HIV infection
8. Known or suspected individual hypersensitivity to any component of the product
9. Use of hormonal contraceptives, stilbestrol/ d.e.s., primidone, fluoxetine, phenylpropanolamine, methylphenidate, troglitazone, gemfibrozil, cerivastatin, isotretinoin

Study & Design

• Study Type: Interventional
• Study Design: Not specified